The Business of Alt Protein: Bringing Cultivated Meat to Market in the United States
Event description
In late 2022, the cultivated meat industry hit an important milestone – UPSIDE Foods became the first cultivated meat company to successfully complete the U.S. Food & Drug Administration (FDA)’s pre-market consultation. The FDA has also shared in a recent update that it is currently in pre-market consultation discussions with other cultivated meat companies.
As we come closer to full regulatory approval, join GFI experts to review the current status of the cultivated meat industry and to take a deep dive into the recent advancements that have taken place in the United States. In this webinar we will cover:
- Overview of the cultivated meat production process
- The US regulatory pathway
- Consumer messaging and nomenclature
- Audience Q&A with GFI scientific, regulatory, and market experts
Meet the speakers
Our speakers today include experts from GFI’s corporate engagement, science and technology, and policy teams. We will be joined by:
- Faraz Harsini, Senior Scientist, Bioprocessing
- Laura Braden, Lead Regulatory Counsel
- Madeline Cohen, Regulatory Attorney
- Emma Ignaszewski, Associate Director, Industry Intelligence & Initiatives
Upcoming events
View all events
The Science of Alt Protein: Are alternative protein products the ultra-processed exception?
Join Dr. Michael Greger for a data-driven exploration of the health effects of plant-based meats compared to their animal-based counterparts.
Alt Protein Pipelines: Industry-academia partnerships for hands-on learning
Discover best practices from the University of Illinois’s Integrated Bioprocessing Research Laboratory (IBRL).
5th Fermentation-Enabled Alternative Protein Summit
Attend the summit with GFI’s Adam Leman, Ph.D., for an in-depth exploration of the latest technical and commercial insights in the fermentation industry.
